| COVID-19 |
1 |
1 |
| Renal Disease |
0 |
0.69 |
| Chronic Kidney Disease |
0 |
0.58 |
| Kidney |
0 |
0.58 |
| Renal Failure |
0 |
0.58 |
| Hospital |
0 |
0.49 |
| C-Reactive Protein (CRP) |
0 |
0.99 |
| Body Mass Index |
0 |
0.19 |
| Receptors |
0 |
0.19 |
| ACE Inhibitor |
0 |
0.14 |
| Type 2 Diabetes Mellitus |
0 |
0.97 |
| HIV Infection |
0 |
0.13 |
| Europe |
0 |
0.1 |
| Intravenous |
0 |
0.1 |
| NHS |
0 |
0.1 |
| Nucleoside Reverse Transcriptase Inhibitors |
0 |
0.1 |
| Severe Acute Respiratory Syndrome |
0 |
0.1 |
| Socioeconomics |
0 |
0.1 |
| Acute Respiratory Distress Syndrome |
0 |
0.08 |
| Antiretroviral Therapy for HIV Infection |
0 |
0.08 |
| Obesity |
0 |
0.08 |
| Social Determinants of Health |
0 |
0.98 |